Form 4 for SLSN SOLESENCE, INC.
Accepted 2022-11-17 00:00:00 ET · period of report 2022-11-15 · accession 0001209191-22-057747 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-11-17 | 2012-11-17+ | SLSN | JANKOWSKI JESS | Pres, CEO, Dir | S - Sale+OE | $1.48 | -9,505 | 59.0K | -14% | -$14.0K |
| DM | 2022-11-17 | 2012-11-17+ | SLSN | JANKOWSKI JESS | Pres, CEO, Dir | M - OptEx | $0.42 | +9,505 | 59.0K | +19% | +$3,992 |
| DM | 2022-11-17 | 2022-11-15+ | SLSN | JANKOWSKI JESS | Pres, CEO, Dir | M - OptEx | $0.42 | -11.7K | 44.2K | -21% | -$4,916 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2012-11-17 | S | D | 5,800 | $1.40 | 59,000 | D | — | — | |
| 2 | Common | Common Stock | 2012-11-17 | M | D | 1,100 | $0.42 | 60,100 | D | — | — | (F1) These stock options are set to expire on 02/14/2023. Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors. |
| 3 | Common | Common Stock | 2012-11-17 | S | A | 1,100 | $1.41 | 59,000 | D | — | — | |
| 4 | Common | Common Stock | 2012-11-17 | M | A | 1,000 | $0.42 | 60,000 | D | — | — | (F1) These stock options are set to expire on 02/14/2023. Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors. |
| 5 | Common | Common Stock | 2012-11-17 | M | A | 5,800 | $0.42 | 64,800 | D | — | — | (F1) These stock options are set to expire on 02/14/2023. Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors. |
| 6 | Common | Common Stock | 2012-11-17 | S | D | 1,000 | $1.35 | 59,000 | D | — | — | |
| 7 | Common | Common Stock | 2012-11-17 | M | A | 1,000 | $0.42 | 60,000 | D | — | — | (F1) These stock options are set to expire on 02/14/2023. Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors. |
| 8 | Common | Common Stock | 2022-11-17 | S | D | 500 | $1.30 | 59,000 | D | — | — | |
| 9 | Common | Common Stock | 2022-11-17 | M | A | 500 | $0.42 | 59,500 | D | — | — | (F1) These stock options are set to expire on 02/14/2023. Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors. |
| 10 | Common | Common Stock | 2022-11-16 | S | D | 5 | $1.62 | 59,000 | D | — | — | |
| 11 | Common | Common Stock | 2012-11-17 | S | D | 1,000 | $1.45 | 59,000 | D | — | — | |
| 12 | Common | Common Stock | 2022-11-15 | S | D | 2,300 | $1.80 | 59,000 | D | — | — | |
| 13 | Common | Common Stock | 2022-11-15 | M | A | 2,300 | $0.42 | 61,300 | D | — | — | (F1) These stock options are set to expire on 02/14/2023. Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors. |
| 14 | Common | Common Stock | 2022-11-16 | M | A | 5 | $0.42 | 59,005 | D | — | — | (F1) These stock options are set to expire on 02/14/2023. Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors. |
| 15 | Derivative | Common Stock (right to purchase) | 2022-11-16 | M | D | 5 | $0.42 | 53,626 | D | $0.42 · 2014-02-14 to 2023-02-14 | 53,631 Common Stock | (F2) These stock options are set to expire on 02/14/2023. Mr. Jankowski converted and sold these shares through a 10b5-1 Plan that has been established with an independent broker. His goal is to have this broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors. |
| 16 | Derivative | Common Stock (right to purchase) | 2022-11-15 | M | D | 2,300 | $0.42 | 53,631 | D | $0.42 · 2014-02-14 to 2023-02-14 | 55,931 Common Stock | (F2) These stock options are set to expire on 02/14/2023. Mr. Jankowski converted and sold these shares through a 10b5-1 Plan that has been established with an independent broker. His goal is to have this broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors. |
| 17 | Derivative | Common Stock (right to purchase) | 2022-11-17 | M | D | 9,400 | $0.42 | 44,226 | D | $0.42 · 2014-02-14 to 2023-02-14 | 53,626 Common Stock | (F2) These stock options are set to expire on 02/14/2023. Mr. Jankowski converted and sold these shares through a 10b5-1 Plan that has been established with an independent broker. His goal is to have this broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors. |